Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel
ARTIGO
Inglês
Agradecimentos: We would like to thank the reviewers for their insightful commentsand suggestions
Tritryps diseases are devastating parasitic neglected infections caused by Leishmania spp., Trypanosoma cruzi and Trypanosoma brucei subspecies. Together, these parasites affect more than 30 million people worldwide and cause high mortality and morbidity.
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
140907/2013-0
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP
15/10436-6
aberto
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
Laura M. Alcântara, Thalita C.S. Ferreira, Fernanda R. Gadelha, Danilo C. Miguel
Fontes
|
International journal for parasitology: drugs and drug resistance Vol. 8, no. 3 (Dec., 2018), p. 430-439 |